Long-Term Mortality of Stroke Survivors in Parakou: 5-Year Follow-Up.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 27 08 2019
revised: 13 01 2020
accepted: 21 02 2020
pubmed: 23 3 2020
medline: 30 9 2020
entrez: 23 3 2020
Statut: ppublish

Résumé

The burden of stroke is high in Africa, but few data are available on the long-term outcome of strokes in this area. We aimed to study the long-term outcome of stroke survivors in Parakou from 2012 to 2018. It was a cohort study and included 247 stroke patients admitted to the University Hospital of Parakou from January 1, 2012 to April 30, 2018. Each patient was followed up for at least 1 year. The modified RANKIN scale was used to evaluate patients. Verbal autopsy was used to ascertain the cause of death. The survival probability was estimated using the Kaplan-Meier method. Predictors of mortality were estimated using the Cox proportional model and the hazard ratio (HR) and their 95% confidence intervals were determined. The data were analyzed using Stata Software. The mean age was 58.1 ± 13.4 years with a sex ratio of 1.12. Among stroke survivors, the mortality was 10.1% at 3 months, 11.7% at 6 months, 15.4% at 1 year, 21.5% at 3 years, and 23.5% at 5 years. The probability of survival after a stroke was 66.5% at 5 years. Factors associated with mortality were age with adjusted HR 1.4 (1.2-1.7) for each 10 years, male sex with aHR 2.3 (1.2-4.6), history of hypertension with aHR 2.0 (1.0-4.1) and the severity of the initial neurological impairment National Institute of Health Stroke Scale with aHR 1.1 (1.0-1.2) for each 1 point. The main causes of death were recurrent stroke, infectious diseases, and cardiac disease. The proportion of patients with functional disability was 53.8% at 1 year. The quality of life was generally impaired in terms of physical health, personal environment, and finances. The long-term prognosis of stroke patients in Parakou is poor. It requires urgent action to reduce this burden.

Sections du résumé

BACKGROUND BACKGROUND
The burden of stroke is high in Africa, but few data are available on the long-term outcome of strokes in this area.
AIM OBJECTIVE
We aimed to study the long-term outcome of stroke survivors in Parakou from 2012 to 2018.
METHODS OF STUDY METHODS
It was a cohort study and included 247 stroke patients admitted to the University Hospital of Parakou from January 1, 2012 to April 30, 2018. Each patient was followed up for at least 1 year. The modified RANKIN scale was used to evaluate patients. Verbal autopsy was used to ascertain the cause of death. The survival probability was estimated using the Kaplan-Meier method. Predictors of mortality were estimated using the Cox proportional model and the hazard ratio (HR) and their 95% confidence intervals were determined. The data were analyzed using Stata Software.
RESULTS RESULTS
The mean age was 58.1 ± 13.4 years with a sex ratio of 1.12. Among stroke survivors, the mortality was 10.1% at 3 months, 11.7% at 6 months, 15.4% at 1 year, 21.5% at 3 years, and 23.5% at 5 years. The probability of survival after a stroke was 66.5% at 5 years. Factors associated with mortality were age with adjusted HR 1.4 (1.2-1.7) for each 10 years, male sex with aHR 2.3 (1.2-4.6), history of hypertension with aHR 2.0 (1.0-4.1) and the severity of the initial neurological impairment National Institute of Health Stroke Scale with aHR 1.1 (1.0-1.2) for each 1 point. The main causes of death were recurrent stroke, infectious diseases, and cardiac disease. The proportion of patients with functional disability was 53.8% at 1 year. The quality of life was generally impaired in terms of physical health, personal environment, and finances.
CONCLUSIONS CONCLUSIONS
The long-term prognosis of stroke patients in Parakou is poor. It requires urgent action to reduce this burden.

Identifiants

pubmed: 32199774
pii: S1052-3057(20)30168-3
doi: 10.1016/j.jstrokecerebrovasdis.2020.104785
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104785

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Thierry Adoukonou (T)

Department of Neurology, University of Parakou, Parakou, Benin; Clinic of Neurology, University Teaching Hospital of Parakou, Benin; U-1094 INSERM, University of Limoges, CHU Limoges, U-1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, Limoges, France. Electronic address: adoukonouthierry@yahoo.fr.

Mendinatou Agbétou (M)

Department of Neurology, University of Parakou, Parakou, Benin; Clinic of Neurology, University Teaching Hospital of Parakou, Benin.

Roland Bangbotché (R)

Clinic of Neurology, University Teaching Hospital of Parakou, Benin.

Oyéné Kossi (O)

Department of Neurology, University of Parakou, Parakou, Benin; Clinic of Neurology, University Teaching Hospital of Parakou, Benin.

Pervenche Fotso Mefo (P)

Clinic of Neurology, University Teaching Hospital of Parakou, Benin.

Julien Magne (J)

U-1094 INSERM, University of Limoges, CHU Limoges, U-1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, Limoges, France.

Dismand Houinato (D)

U-1094 INSERM, University of Limoges, CHU Limoges, U-1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, Limoges, France; Department of Neurology, University of Abomey-Calavi BP 188 Cotonou, Benin.

Pierre-Marie Preux (PM)

U-1094 INSERM, University of Limoges, CHU Limoges, U-1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, Limoges, France.

Philippe Lacroix (P)

U-1094 INSERM, University of Limoges, CHU Limoges, U-1094, Tropical Neuroepidemiology, Institute of Epidemiology and Tropical Neurology, GEIST, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH